Trials / Completed
CompletedNCT00770796
Statins for Prevention of Contrast Induced Nephropathy
Usefulness of Atorvastatin (80 mg) in Prevention of Contrast-Induced Nephropathy in Patients With Chronic Renal Disease
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 304 (actual)
- Sponsor
- Ospedale Misericordia e Dolce · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
In this randomized study the investigators wish to explore the role of pre-procedural statin therapy for the prevention of contrast induced nephropathy in patients with moderate-to-severe renal dysfunction, submitted to elective coronary or angioplasty.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atorvastatin | 80 mg die |
| DRUG | Placebo |
Timeline
- Start date
- 2006-04-01
- Primary completion
- 2008-03-01
- Completion
- 2008-03-01
- First posted
- 2008-10-10
- Last updated
- 2015-10-16
Source: ClinicalTrials.gov record NCT00770796. Inclusion in this directory is not an endorsement.